Clinical Trial Update: Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of an anti-PD-1 antibody with chemotherapy for pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Anti-PD-1 antibody
• Chemotherapy (unspecified)

Snippet

Sponsor: Zhejiang University | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED